Premium
Biopolymer‐based Carriers for DNA Vaccine Design
Author(s) -
Franck Christoph O.,
Fanslau Luise,
Bistrovic Popov Andrea,
Tyagi Puneet,
Fruk Ljiljana
Publication year - 2021
Publication title -
angewandte chemie
Language(s) - English
Resource type - Journals
eISSN - 1521-3757
pISSN - 0044-8249
DOI - 10.1002/ange.202010282
Subject(s) - immunogenicity , biocompatibility , dna vaccination , context (archaeology) , dna , biopolymer , transfection , virology , human immunodeficiency virus (hiv) , nanotechnology , chemistry , materials science , biology , immunology , immune system , gene , polymer , biochemistry , paleontology , plasmid , organic chemistry
Over the last 30 years, genetically engineered DNA has been tested as novel vaccination strategy against various diseases, including human immunodeficiency virus (HIV), hepatitis B, several parasites, and cancers. However, the clinical breakthrough of the technique is confined by the low transfection efficacy and immunogenicity of the employed vaccines. Therefore, carrier materials were designed to prevent the rapid degradation and systemic clearance of DNA in the body. In this context, biopolymers are a particularly promising DNA vaccine carrier platform due to their beneficial biochemical and physical characteristics, including biocompatibility, stability, and low toxicity. This article reviews the applications, fabrication, and modification of biopolymers as carrier medium for genetic vaccines.